Wednesday, February 28, 2018

Helen Taylor Tells Her Story Of Battle With Myasthenia Gravis On Rare Disease Day

Left: Helen Taylor before she fell ill. Right: During hospital treatment
A woman in Ipswich Suffolk, England had her life turned upside by a disabling and little-understood illness. She shared her story to mark Rare Disease Day.

At the end of 2016, Helen Taylor was diagnosed with myasthenia gravis (MG), a condition that is thought to affect just 11,000 people in the UK and causes muscle weakness.

When the disease struck, Ms Taylor, now 47, was juggling an extremely

Tuesday, January 30, 2018

Study Suggests That Biological Agents Could Balance Immune Response In MG Patience

Biological agents that target inflammation-generating immune cells and signaling molecules could be used to treat myasthenia gravis, French researchers report.

Biologics have helped people with other autoimmune diseases, so they might be able to restore balance to MG patients’ immune system, the team said.

Wednesday, January 24, 2018

Here's Looking At You Kid - Your Eyes And Your Health

The eyes may be a window to the soul, but they also offer a lot of information about your overall health. This doesn't simply mean your ability to correctly read an eye chart, either. Everything from liver health to cholesterol levels can be reflected by the eyes in some way.

The eyes also contain a wealth of insight about the rest of your body's ability to function. Read on to see what your eyes have to say.

Sunday, December 17, 2017

Antibody Treatment For Myasthenia Gravis From Argenx Proves Effective

A Phase II proof of concept study has shown that one of Argenx’ antibodies is effective in treating the neuromuscular disease myasthenia gravis.

Argenx has released the results from a Phase II trial with ARGX-113 (efgartigimod), in which the antibody therapy has proved to provide a significant improvement in patients with generalized myasthenia gravis, a form of the disease that affects the strength of multiple muscles simultaneously. Argenx’ stock on Euronext Brussels is up by 24% a few hours after it opened this

Thursday, November 16, 2017

Myasthenia Gravis Symptoms Could Be Relieved By Cognitive Behavioral Therapy

Cognitive Behavioral Therapy (CBT) should be considered as a first-line treatment for myasthenia gravis (MG) patients who also suffer from anxiety, depression, or insomnia disorders, a new study urges.

The study, “Cognitive-Behavioral Therapy for Psychiatric Comorbidity in a Case of Muscle-Specific Kinase–Positive Myasthenia Gravis,” appeared in the journal The Primary Care Companion for CNS Disorders.

MG patients frequently have depression and anxiety. Medications usually help, though some patients suffer adverse events. CBT, a type of psychotherapy, can

Tuesday, November 14, 2017

Relatives Of Myasthenia Gravis Patients Have Higher Risk Of Developing The Disease

Researchers in Taiwan have found that first-degree relatives of individuals with myasthenia gravis have a higher risk of developing the disease. The risk is greater for patients’ siblings, the study found.

The study, “Familial aggregation of myasthenia gravis in affected families: a population-based study,” appeared in the journal Clinical Epidemiology.

Wednesday, October 18, 2017

MG Respiratory Failure Requires Specific Treatments in the ER, Review Contends

Myasthenic crisis is a common complication in patients with myasthenia gravis (MG), marked by exacerbation of MG symptoms and respiratory failure. But with the rarity of MG, and its similarity to a range of other neuromuscular diseases, proper detection and treatment might fail, researchers argue.

Wednesday, September 27, 2017

It Wasn't A Stroke But All The Signs Pointed That Way

“Mom?” the middle-aged man asked. He recognized the voice, but the words were muffled and strange. I’ll be right over, he said into the phone. The 15-minute drive from his small Connecticut town to his mother’s seemed to last forever. Had she had a stroke? She was 94, and though she’d always been

Friday, September 8, 2017

Vitamin D3 Deficiency Linked To Myasthenia Gravis - Study Confirms

Vitamin D From Fish Oil 

Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder. Vitamin D has important roles both in the autoimmune response and in skeletal muscles. We determined the levels of 25-hydroxy vitamin D [25(OH)D] in patients with MG and in healthy subjects to determine whether vitamin D deficiency is present in MG and whether vitamin D supplementation has beneficial effects on fatigue.